Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120


West Nile virus T-cell ligand sequences shared with other flaviviruses: a multitude of variant sequences as potential altered peptide ligands.

Jung KO, Khan AM, Tan BY, Hu Y, Simon GG, Nascimento EJ, Lemonnier F, Brusic V, Miotto O, Tan TW, Marques ET, Dhalia R, Salmon J, August JT.

J Virol. 2012 Jul;86(14):7616-24. doi: 10.1128/JVI.00166-12. Epub 2012 May 9.


Conservation and variability of West Nile virus proteins.

Koo QY, Khan AM, Jung KO, Ramdas S, Miotto O, Tan TW, Brusic V, Salmon J, August JT.

PLoS One. 2009;4(4):e5352. doi: 10.1371/journal.pone.0005352. Epub 2009 Apr 29.


Altered effector functions of virus-specific and virus cross-reactive CD8+ T cells in mice immunized with related flaviviruses.

Trobaugh DW, Yang L, Ennis FA, Green S.

Eur J Immunol. 2010 May;40(5):1315-27. doi: 10.1002/eji.200839108.


Recovery of West Nile Virus Envelope Protein Domain III Chimeras with Altered Antigenicity and Mouse Virulence.

McAuley AJ, Torres M, Plante JA, Huang CY, Bente DA, Beasley DW.

J Virol. 2016 Apr 14;90(9):4757-70. doi: 10.1128/JVI.02861-15. Print 2016 May.


CD8(+) T cell-mediated immune responses in West Nile virus (Sarafend strain) encephalitis are independent of gamma interferon.

Wang Y, Lobigs M, Lee E, Koskinen A, Müllbacher A.

J Gen Virol. 2006 Dec;87(Pt 12):3599-609.


High clonality of virus-specific T lymphocytes defined by TCR usage in the brains of mice infected with West Nile virus.

Kitaura K, Fujii Y, Hayasaka D, Matsutani T, Shirai K, Nagata N, Lim CK, Suzuki S, Takasaki T, Suzuki R, Kurane I.

J Immunol. 2011 Oct 15;187(8):3919-30. doi: 10.4049/jimmunol.1100442. Epub 2011 Sep 9.


A DNA vaccine encoding the E protein of West Nile virus is protective and can be boosted by recombinant domain DIII.

Schneeweiss A, Chabierski S, Salomo M, Delaroque N, Al-Robaiy S, Grunwald T, Bürki K, Liebert UG, Ulbert S.

Vaccine. 2011 Aug 26;29(37):6352-7. doi: 10.1016/j.vaccine.2011.04.116. Epub 2011 May 17.


Distinguishing West Nile virus infection using a recombinant envelope protein with mutations in the conserved fusion-loop.

Chabierski S, Barzon L, Papa A, Niedrig M, Bramson JL, Richner JM, Palù G, Diamond MS, Ulbert S.

BMC Infect Dis. 2014 May 9;14:246. doi: 10.1186/1471-2334-14-246.


Antigen-specific cytotoxic T lymphocytes protect against lethal West Nile virus encephalitis.

Purtha WE, Myers N, Mitaksov V, Sitati E, Connolly J, Fremont DH, Hansen TH, Diamond MS.

Eur J Immunol. 2007 Jul;37(7):1845-54.


Serosurvey of West Nile virus and other flaviviruses of the Japanese encephalitis antigenic complex in birds from Andalusia, southern Spain.

García-Bocanegra I, Busquets N, Napp S, Alba A, Zorrilla I, Villalba R, Arenas A.

Vector Borne Zoonotic Dis. 2011 Aug;11(8):1107-13. doi: 10.1089/vbz.2009.0237. Epub 2010 Dec 13.


Identification of class I HLA T cell control epitopes for West Nile virus.

Kaabinejadian S, Piazza PA, McMurtrey CP, Vernon SR, Cate SJ, Bardet W, Schafer FB, Jackson KW, Campbell DM, Buchli R, Rinaldo CR, Hildebrand WH.

PLoS One. 2013 Jun 10;8(6):e66298. doi: 10.1371/journal.pone.0066298. Print 2013.


Use of envelope domain III protein for detection and differentiation of flaviviruses in the Free State Province, South Africa.

Mathengtheng L, Burt FJ.

Vector Borne Zoonotic Dis. 2014 Apr;14(4):261-71. doi: 10.1089/vbz.2013.1407. Epub 2014 Apr 1.


West Nile virus diagnosis and vaccination: using unique viral peptide sequences to evoke specific immune responses.

Capone G, Lucchese G, Calabrò M, Kanduc D.

Immunopharmacol Immunotoxicol. 2013 Feb;35(1):64-70. doi: 10.3109/08923973.2012.736521. Epub 2012 Nov 2.


Comprehensive analysis of west nile virus-specific T cell responses in humans.

Lanteri MC, Heitman JW, Owen RE, Busch T, Gefter N, Kiely N, Kamel HT, Tobler LH, Busch MP, Norris PJ.

J Infect Dis. 2008 May 1;197(9):1296-306. doi: 10.1086/586898.


Supplemental Content

Support Center